CSF3 and myeloid sarcoma: In one study performed in Italy, 10 patients with secondary progressive MS received a mobilization regimen of high-dose cyclophosphamide (4 g/m2) and granulocyte-colony-stimulating factor (G-CSF), followed by the BEAM conditioning regimen (carmustine, etoposide, cytosine-arabinoside, and melphalan).[58] This was then followed by autologous peripheral blood stem cell transplantation.